18-Feb-2026
Download PDF
Lincoln Pharma
We wish to inform you that the Company participated in investor conference- Call Conference on February 18 2026. No Unpublished Price Sensitive Information (UPSI) was shared / discussed in the meeting with investors.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
